By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it has signed a co-marketing agreement with Covaris to combine technologies aimed at next-generation sequencing workflows.

The Hopkinton, Mass.-based firm said that the partners will leverage Caliper's automation and microfluidics technologies and Covaris' acoustic DNA-shearing platforms to develop automated workflows.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.